Pancreatic cancer
Conditions
Interventions
Resection of preoperatively undetectable intraabodominal distant metastasis and primary cancer, if R0 resection is possible.
Sponsors
Hepato-Biliary Pancreatic surgery, Tohoku University Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) histolycally proven invasive pancreatic ductal adenocarcinoma (2) no distant metastasis with preoperative imaging (CT, MRI, FDG-PET-CT) (3) R0 resection is possible for primary cancer (4) with tolerable health to operation (5) no prior therapy for pancreas cancer (6) not enrolled in other study with primary endpoint of resection or survival (7) no other active cancer (8) with consent in a writing form (9) 20 years old or older (10) with judgement
Exclusion criteria
Exclusion criteria: (1) not diagnosed as invasive pancreatic ductal adenocarcinoma (2) with distant metastasis (3) R2 resection is expected (4) without tlerable health to operation (5) recurrent pancreatic cancer (6) enrolled in other study with primary endpoint of resection or survival (7) with another active cancer (8) in pregnancy (9) younger than 20 years old (10) without judgement
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Perioperative safety | — |
Secondary
| Measure | Time frame |
|---|---|
| - Relapse free survival, - Type of recurrence, - Time course of tumor marker, - The rate of administration of postoperarive adjuvant chemotherapy, - Survival time after recurrence - Over all survival | — |
Countries
Japan
Contacts
Public ContactHiroki Hayashi
Tohoku University Hospital Hepato-Biliary Pancreatic surgery
Outcome results
None listed